1700006A11Rik Activators encompass a diverse array of chemical compounds that indirectly influence the functional activity of 1700006A11Rik across various cellular signaling pathways. For example, Forskolin, by increasing cAMP levels, activates PKA, which could directly phosphorylate 1700006A11Rik or modify its regulatory protein interactions, thereby enhancing its activity. PMA mimics DAG and activates PKC, potentially resulting in phosphorylation events that activate 1700006A11Rik. Ionomycin facilitates calcium influx, triggering calcium-dependent kinases that might phosphorylate and activate 1700006A11Rik. Similarly, Sphingosine 1-phosphate signals through its receptors, potentially impacting 1700006A11Rik activation states via downstream phosphorylation events. The tyrosine kinase inhibition by Genistein could diminish competitive signaling, potentially enhancing pathways that activate 1700006A11Rik. LY294002 and U0126, by inhibiting PI3K and MEK1/2, respectively, could alter intracellular signaling, leading toactivation of 1700006A11Rik through alternative routes. SB203580 alters p38 MAPK activity, potentially favoring 1700006A11Rik activation, while EGCG's kinase inhibition could similarly streamline signaling towards 1700006A11Rik enhancement.
On the other hand, A23187 (Calcimycin) and Rapamycin act through the modulation of intracellular calcium and mTOR inhibition respectively, which may lead to the engagement of 1700006A11Rik in calcium-dependent pathways or autophagy-related processes. Staurosporine, despite general kinase inhibition, may relieve negative regulatory constraints on 1700006A11Rik, leading to its activation. Collectively, these activators utilize a broad spectrum of biochemical mechanisms to facilitate enhanced activity of 1700006A11Rik, leveraging direct and indirect modulation of cellular signaling pathways without necessitating the upregulation of gene expression or direct protein activation. Each chemical operates within a unique facet of cellular biochemistry, ensuring that 1700006A11Rik is engaged and functionally active, underpinning its diverse roles in cellular physiology.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $40.00 $129.00 $210.00 $490.00 $929.00 | 119 | |
PMA functions as a diacylglycerol (DAG) analogue, activating protein kinase C (PKC) which can phosphorylate and thus, activate 1700006A11Rik if it is a substrate or involved in associated signaling pathways. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $76.00 $265.00 | 80 | |
Ionomycin acts as an ionophore that increases intracellular calcium levels, potentially activating calcium-dependent protein kinases which can phosphorylate and thereby enhance the activity of 1700006A11Rik. | ||||||
D-erythro-Sphingosine-1-phosphate | 26993-30-6 | sc-201383 sc-201383D sc-201383A sc-201383B sc-201383C | 1 mg 2 mg 5 mg 10 mg 25 mg | $162.00 $316.00 $559.00 $889.00 $1693.00 | 7 | |
Sphingosine 1-phosphate binds to its G-protein-coupled receptors, initiating a signaling cascade that could culminate in the activation of 1700006A11Rik through phosphorylation or allosteric interactions. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $26.00 $92.00 $120.00 $310.00 $500.00 $908.00 $1821.00 | 46 | |
Genistein is an inhibitor of tyrosine kinases, which may lead to a reduction in competitive signaling pathways, thereby enhancing signaling processes that activate 1700006A11Rik. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $121.00 $392.00 | 148 | |
LY294002 is a PI3K inhibitor, which can alter the PI3K/AKT pathway, potentially resulting in the activation of 1700006A11Rik by changing the phosphorylation dynamics within the cell. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $88.00 $342.00 | 284 | |
SB203580 is a p38 MAPK inhibitor, which could shift signaling dynamics to favor alternative pathways that activate 1700006A11Rik through phosphorylation or other regulatory mechanisms. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $42.00 $72.00 $124.00 $238.00 $520.00 $1234.00 | 11 | |
EGCG can inhibit multiple kinases, potentially reducing competitive signaling and enhancing pathways that lead to the activation of 1700006A11Rik. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $54.00 $128.00 $199.00 $311.00 | 23 | |
A23187 acts as a calcium ionophore, raising intracellular calcium levels and potentially activating calcium-dependent signaling pathways that could enhance the activity of 1700006A11Rik. | ||||||
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $150.00 $388.00 | 113 | |
Staurosporine, though a broad-spectrum kinase inhibitor, could paradoxically activate 1700006A11Rik by inhibiting kinases that negatively regulate it. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $62.00 $155.00 $320.00 | 233 | |
Rapamycin inhibits mTOR, which could activate autophagy-related pathways where 1700006A11Rik might be involved, leading to its functional activation. | ||||||